Certified by Founder Lodge
Nimbus Therapeutics
United States - Cambridge, Massachusetts START UP
1 Disclosed Funding Rounds $125,000,000
0 Participating Investments
- Founded date
2009
- Operating Status
Active
- Last Funding Type
Seed
- Company Type
For Profit
- Website
- Contact
- Social Links
At Nimbus, we design breakthrough medicines. Utilizing our powerful structure-based drug discovery engine, we create potent and selective small molecule compounds targeting proteins that are
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| September, 13 ,2022 | Unknown | $125,000,000 |
Bain Capital
Atlas Venture
SV Health Investors
Pfizer
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Further AI | $5,000,000 | (Apr 3, 2025)
SchoolAI | $25,000,000 | (Apr 3, 2025)
Vivere | $7,500,000 | (Apr 3, 2025)
TrialKit | $4,250,000 | (Apr 3, 2025)
TwinKnowledge | $3,700,000 | (Apr 3, 2025)
